JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
INSI
5776
DELISTED
Insight Select Income Fund
INSI
| $45.7K | ﹤0.01% |
2,862
+928
| +48% | +$14K |
2023 Q3
1 quarter
|
|
|
IBMN
5777
DELISTED
iShares iBonds Dec 2025 Term Muni Bond ETF
IBMN
| $45.5K | ﹤0.01% |
1,714
-4,461
| -72% | -$117K |
2023 Q3
1 quarter
|
|
|
BLACR
5778
DELISTED
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
| $45K | ﹤0.01% |
+300,000
| New | +$48.5K |
2023 Q4
0 quarters
|
|
5779
Compugen
CGEN
$222M
| $44.9K | ﹤0.01% |
22,694
+22,688
| +378,133% | +$19.8K |
2023 Q3
1 quarter
|
|
5780
CALL
Darling Ingredients
DAR
$9.73B
| $44.9K | ﹤0.01% |
+900
| New | +$40.9K |
2023 Q4
0 quarters
|
|
5781
AltShares Merger Arbitrage ETF
ARB
$101M
| $44.8K | ﹤0.01% |
+1,676
| New | +$44.2K |
2023 Q4
0 quarters
|
|
|
EGPT
5782
DELISTED
VanEck Egypt Index ETF
EGPT
| $44.6K | ﹤0.01% |
+1,842
| New | +$44.3K |
2023 Q4
0 quarters
|
|
5783
Innovator Buffer Step-Up Strategy ETF
BSTP
$59.3M
| $44.5K | ﹤0.01% |
1,564
-188
| -11% | -$5.11K |
2023 Q3
1 quarter
|
|
5784
iShares Core 5-10 Year USD Bond ETF
IMTB
$265M
| $44.5K | ﹤0.01% |
1,022
-1,173
| -53% | -$48.7K |
2021 Q3
9 quarters
|
|
5785
Value Line
VALU
$370M
| $44.5K | ﹤0.01% |
912
+364
| +66% | +$15.5K |
2017 Q4
24 quarters
|
|
5786
Union Bankshares
UNB
$114M
| $44.4K | ﹤0.01% |
1,449
+1,444
| +28,880% | +$39.5K |
2017 Q4
24 quarters
|
|
5787
ALPS Active Equity Opportunity ETF
RFFC
$30.6M
| $44.4K | ﹤0.01% |
936
| – | – |
2022 Q4
4 quarters
|
|
5788
Beyond Air
XAIR
$2.72M
| $44.3K | ﹤0.01% |
57
| – | – |
2023 Q2
2 quarters
|
|
|
MREO
5789
Mereo BioPharma
MREO
$58.6M
| $44.2K | ﹤0.01% |
19,118
-113,683
| -86% | -$217K |
2021 Q3
9 quarters
|
|
5790
AdvisorShares Pure US Cannabis ETF
MSOS
$906M
| $44.1K | ﹤0.01% |
+6,288
| New | +$41.8K |
2023 Q4
0 quarters
|
|
|
IMA
5791
ImageneBio Inc
IMA
$52M
| $44K | ﹤0.01% |
1,861
+488
| +36% | +$15.9K |
2021 Q2
10 quarters
|
|
|
KZR
5792
DELISTED
Kezar Life Sciences
KZR
| $43.8K | ﹤0.01% |
4,626
-91,236
| -95% | -$802K |
2018 Q3
21 quarters
|
|
5793
Ramaco Resources Class B
METCB
$280M
| $43.6K | ﹤0.01% |
3,628
+385
| +12% | +$4.63K |
2023 Q2
2 quarters
|
|
|
CUTR
5794
DELISTED
Cutera, Inc.
CUTR
| $43.1K | ﹤0.01% |
12,236
-7,662
| -39% | -$23.3K |
2016 Q4
28 quarters
|
|
5795
PUT
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $43.1K | ﹤0.01% |
+900
| New | +$40.3K |
2023 Q4
0 quarters
|
|
5796
Ardagh Metal Packaging
AMBP
$2.62B
| $43.1K | ﹤0.01% |
11,224
-124,581
| -92% | -$433K |
2022 Q3
5 quarters
|
|
5797
Invesco AI and Next Gen Software ETF
IGPT
$1.42B
| $43K | ﹤0.01% |
1,113
-601
| -35% | -$20.9K |
2019 Q2
18 quarters
|
|
5798
First Trust US Equity Opportunities ETF
FPX
$1.47B
| $42.6K | ﹤0.01% |
444
+55
| +14% | +$4.74K |
2022 Q4
4 quarters
|
|
5799
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$111M
| $42.4K | ﹤0.01% |
412
-58
| -12% | -$4.98K |
2021 Q1
11 quarters
|
|
5800
VanEck Green Bond ETF
GRNB
$188M
| $42.4K | ﹤0.01% |
1,777
+27
| +2% | +$620 |
2023 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.